The BRCA1 and BRCA2 PGVs were identified in women diagnosed with a first primary lobular cancer who then developed a second primary breast or ovarian cancer, respectively, whereas the TP53 PGV was identified in a woman with a first primary lobular breast cancer at age 21 who then developed bilateral disease. This evidence concerns the gene TP53 and ovarian carcinoma.